XML 102 R87.htm IDEA: XBRL DOCUMENT v3.25.2
Redeemable Convertible Preferred Stock and Stockholders' Deficit - Additional Information (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 19, 2024
Jul. 05, 2024
Jul. 01, 2024
Jun. 28, 2024
Dec. 18, 2023
Aug. 01, 2023
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Class of Stock [Line Items]                          
Preferred stock, shares authorized               100,000,000 100,000,000 100,000,000   100,000,000 100,000,000
Preferred stock, shares outstanding               0 0 0   0 0
Preferred stock, par value               $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001
Warrants converted into warrants exercisable                       767,697 16,151
General and administrative             $ 7,043,000 $ 7,311,000 $ 6,386,000 $ 13,697,000 $ 20,746,000 $ 28,399,000 $ 46,024,000
Number of shares authorized             1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000
Number of shares outstanding           1,892,058 2,574,783 1,918,927 1,915,956 1,918,927 2,574,783 2,710,607 1,907,529
Warrants outstanding                       14,589  
Common stock, par value             $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Warrants exercisable price                       $ 202.5  
Warrant liabilities             $ 7,381,000 $ 2,113,000 $ 3,329,000 $ 2,113,000 $ 7,381,000 $ 4,567,000 $ 6,765,000
Issuance of convertible preferred stock for the exercise of warrant (in shares)           750,394              
Stock issued during period value                 378,000     1,007,000  
Additional paid-in capital           $ 15,200,000 $ 150,696,000 $ 144,771,000 $ 143,949,000 $ 144,771,000 $ 150,696,000 $ 152,596,000 $ 143,010,000
ChEF Purchase Agreement | Chardan Equity Facility                          
Class of Stock [Line Items]                          
Number of shares sold per unit                       75,618  
Amount received on shares sold per unit                       $ 1,000,000  
Stock issued during period value         $ 100,000,000                
Expense of issuance of commitment shares         100,000                
Additional paid-in capital         100,000                
Structuring fee payable         $ 100,000                
Common Stock                          
Class of Stock [Line Items]                          
Conversion of shares 90,407                        
Stock isssued during the period (in shares)                 5,730     75,618  
Common Stock | ChEF Purchase Agreement | Chardan Equity Facility                          
Class of Stock [Line Items]                          
Number of shares outstanding         379,299                
Percentage of common stock, shares, outstanding         19.99%                
Commitment Shares | ChEF Purchase Agreement | Chardan Equity Facility                          
Class of Stock [Line Items]                          
Number of shares sold per unit         1,421                
Additional Paid-in Capital                          
Class of Stock [Line Items]                          
Stock issued during period value                 $ 378,000     $ 1,007,000  
Public Warrant                          
Class of Stock [Line Items]                          
Warrants outstanding                       662,701  
Warrant liabilities                       $ 13,206,720  
Issuance of convertible preferred stock for the exercise of warrant (in shares)                       750,383  
Public Warrant | Scenario Plan Three                          
Class of Stock [Line Items]                          
Warrants redumption price per share                       $ 0.25  
Stock price                       316.75  
Public Warrant | Scenario Plan Four                          
Class of Stock [Line Items]                          
Warrants redumption price per share                       2.5  
Stock price                       $ 176  
Private Placement with RTW                          
Class of Stock [Line Items]                          
Warrants converted into warrants exercisable       90,407                  
Net proceeds from offering     $ 2,500,000                    
Offering cost     $ 200,000                    
Public Offering                          
Class of Stock [Line Items]                          
Warrants converted into warrants exercisable     86,440 576,261                  
Net proceeds from offering     $ 15,200,000                    
Underwriting discounts     1,000,000                    
Offering cost     $ 1,000,000                    
Sale of stock       $ 30                  
Number of shares sold per unit     662,701 576,261                  
Underwriters                          
Class of Stock [Line Items]                          
Net proceeds from offering   $ 2,200,000                      
Number of shares sold per unit   77,091                      
Warrants exercisable price   $ 30                      
Public Offering Warrants and Share Overallotment                          
Class of Stock [Line Items]                          
Net proceeds from offering     $ 17,400,000                    
Offering cost     800,000                    
Issue-date estimated fair value     13,200,000                    
Public Offering Warrants and Share Overallotment | Common Stock                          
Class of Stock [Line Items]                          
Net proceeds from offering     5,100,000                    
Public Offering Warrants and Share Overallotment | Additional Paid-in Capital                          
Class of Stock [Line Items]                          
Net proceeds from offering     $ 5,100,000                    
Private Placement Warrants                          
Class of Stock [Line Items]                          
Warrants outstanding                       90,407  
Compute Health                          
Class of Stock [Line Items]                          
Sale of stock                       $ 10  
Compute Health | IPO                          
Class of Stock [Line Items]                          
Number of shares sold per unit                       1  
Class of Warrant Exchanged                       0.6125  
Compute Health | Public Warrant                          
Class of Stock [Line Items]                          
Number of shares sold per unit                       0.5  
Series A Preferred Stock                          
Class of Stock [Line Items]                          
Preferred stock voting rights                       no  
Dividends declared                       $ 0  
Preferred stock liquidation preference                       In the event of any voluntary or involuntary liquidation, dissolution, or winding-up of the Company, payment shall be made to the holders of shares of Series A Preferred Stock on a pari passu basis with all holders of Common Stock. Each Series A Preferred Stock holder shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of Common Stock would receive if such holder’s Series A Convertible Preferred Stock were fully converted to Common Stock plus an additional amount equal to any dividends declared but unpaid to such share.  
Preferred stock conversion rights                       Each share of Series A Preferred Stock is convertible after the date that the Company’s stockholders approve the conversion of the Series A Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE (the “Series A Stockholder Approval”). Upon the Series A Stockholder Approval, each share of Series A Preferred Stock then outstanding shall automatically convert into (i) a number of shares of Common Stock equal to the number of Series A Preferred Stock outstanding at the time of conversion, adjustable for certain dilutive events, and (ii) pre-funded conversion warrants in the form agreed by the holder and the Company, exercisable for a number of shares of Common Stock equal to the number of Series A Preferred Stock outstanding at the time of conversion, adjustable for certain dilutive events. The Series A Stockholder Approval was received on December 19, 2024.  
Preferred stock redemption basis                       Each share of Series A Preferred Stock outstanding on December 31, 2026 (the “Redemption Date”) shall be automatically redeemed by the Company for cash at a redemption price equal to the volume-weighted average price per share of the Common Stock on the NYSE during the twenty consecutive trading day period ending and including the trading day immediately preceding the Redemption Date (the “Redemption Price”). The Series A Preferred Stock is redeemable at a determinable price (the Redemption Price) on a fixed date (the Redemption Date), which results in mezzanine equity classification (outside of permanent equity) on the Company’s consolidated balance sheet.  
Shares issued upon conversion 2,260,159                        
Series A Preferred Stock | Private Placement with RTW                          
Class of Stock [Line Items]                          
Preferred stock, par value       $ 0.0001                  
Offering cost       $ 200,000                  
Issue-date estimated fair value       1,700,000                  
Gross proceeds from offering       1,000,000                  
Reduction in proceeds from offering       100,000                  
General and administrative       $ 100,000                  
Number of shares sold per unit       2,260,159                  
Class A Common Stock                          
Class of Stock [Line Items]                          
Number of shares sold per unit                       1  
Common stock, par value                       $ 0.0001  
Class A Common Stock | Compute Health | IPO                          
Class of Stock [Line Items]                          
Sale of stock                       $ 11.5  
Shares issuable for each outstanding warrants exercised                       0.056818